SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Priv. Ord Regulatory News (CTPE)

Share Price Information for Ct Priv. Ord (CTPE)

Share Price is delayed by 15 minutes
Get Live Data
500.00    7.50 (1.53%)
Bid:
495.00
Ask:
500.00
Spread: 5.00 (1.01%)
Market Cap: £357.51m
CTPE Live PriceLast checked at - London Stock Exchange

Intraday Ct Priv. Ord Share Chart

Kepler Trust Intelligence: New Research

29 Dec 2022 07:00

RNS Number : 0996L
CT Private Equity Trust PLC
29 December 2022
 

CT Private Equity: New Research 

29/12/2022

CTPE's differentiated strategy continues to deliver strong results…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPGPAPUPPGGR
Date   Source Headline
24th Sep 20242:37 pmRNSHolding(s) in Company
24th Sep 20242:35 pmRNSDirector Declaration
2nd Sep 202410:00 amRNSTotal Voting Rights
29th Aug 20247:00 amRNSInterim Results and dividend Announcement
1st Aug 20241:31 pmRNSTotal Voting Rights
1st Jul 20249:51 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSDirector Declaration
3rd Jun 202412:03 pmRNSTotal Voting Rights
29th May 20243:24 pmRNSResults of AGM and Directorate Change
29th May 202411:51 amRNS1st Quarter Results and Dividend Announcement
15th May 20247:00 amRNSKepler Trust Intelligence: New Research
2nd May 20245:27 pmRNSTransaction in Own Shares
2nd May 20244:58 pmRNSHolding(s) in Company
1st May 20249:43 amRNSTotal Voting Rights
29th Apr 20243:08 pmRNSDirector/PDMR Shareholding
26th Apr 20245:08 pmRNSDirector/PDMR Shareholding
16th Apr 20244:22 pmRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 20249:08 amRNSTransaction in Own Shares
3rd Apr 20241:11 pmRNSDirector/PDMR Shareholding
3rd Apr 20247:00 amRNSPreliminary Annual Results and Quarterly Dividend
2nd Apr 202411:53 amRNSInvestor Presentation
2nd Apr 202410:36 amRNSTotal Voting Rights
1st Mar 20249:16 amRNSTotal Voting Rights
1st Feb 202411:18 amRNSTotal Voting Rights
2nd Jan 20249:14 amRNSTotal Voting Rights
20th Dec 20239:53 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSKepler Trust Intelligence: New Research
19th Dec 20237:00 amRNSDirectorate Change
8th Dec 202312:01 pmRNSTransaction in Own Shares
1st Dec 202310:19 amRNSTotal Voting Rights
30th Nov 20233:32 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNS3rd Quarter Results and Dividend announcement
13th Nov 20239:42 amRNSInvestor Presentation
1st Nov 20239:52 amRNSTotal Voting Rights
31st Oct 202311:39 amRNSMajor Shareholding Notifications
17th Oct 202310:01 amRNSMajor Shareholding Notifications
2nd Oct 20239:30 amRNSTotal Voting Rights
1st Sep 20239:23 amRNSTotal Voting Rights
23rd Aug 20237:00 amRNSHalf-year Report
7th Aug 202310:58 amRNSInvestor Presentation
1st Aug 20239:44 amRNSTotal Voting Rights
3rd Jul 202311:27 amRNSTotal Voting Rights
6th Jun 20237:00 amRNSKepler Trust Intelligence: New Research
1st Jun 20239:57 amRNSTotal Voting Rights
26th May 20232:54 pmRNSDirector/PDMR Shareholding
24th May 20233:25 pmRNSDirector Declaration
23rd May 20234:52 pmRNSAnnual General Meeting and Retirement of Director
23rd May 202311:30 amRNSQuarterly net asset value and dividend
2nd May 202310:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.